Acta Agriculturae Zhejiangensis ›› 2025, Vol. 37 ›› Issue (11): 2258-2264.DOI: 10.3969/j.issn.1004-1524.20240914

• Animal Science • Previous Articles     Next Articles

Comparative study on inactivated vaccines and similar products against Escherichia coli and Clostridium perfringens

LIU Zewen(), YUAN Fangyan, LIU Wei, GAO Ting, YANG Keli, GUO Rui, LI Chang, WU Qiong, ZHU Jiajia, TIAN Yongxiang, ZHOU Danna()   

  1. Key Laboratory of Prevention and Control Agents for Animal Bacteriosis, Ministry of Agriculture and Rural Affairs, Hubei Provincial Key Laboratory of Livestock and Poultry of Pathogen Microbiology, Institute of Animal Husbandry and Veterinary, Hubei Academy of Agricultural Sciences, Wuhan 430064,China
  • Received:2024-10-25 Online:2025-11-25 Published:2025-12-08

Abstract:

In order to compare the safety and immune efficacy of the dual inactivated vaccine for piglet Escherichia coli disease and Clostridium perfringens(bivalent vaccine) developed by the author team with similar dual vaccine and individual vaccines, the inactivated vaccine in our laboratory was compared with the trivalent inactivated vaccine against Escherichia coli and the inactivated vaccine against C-type Clostridium perfringens produced by domestic biopharmaceutical companies, as well as the combined inactivated vaccine produced by a foreign company. Comparative experiments were conducted on traits, sterility testing, safety, and immune protection effects under the same conditions. The results showed that the inactivated vaccines were qualified in terms of characteristics and sterility compared with domestic and imported vaccines, and all vaccines were safe for mice and weaned piglets. The protection rate of the inactivated vaccine against various strains of Escherichia coli and C-type Clostridium perfringens achieved 80%-100%, with no significant difference in efficacy compared with various single vaccines and imported vaccines of the same type. The comparison results showed that the quality of the inactivated vaccine developed by author team is not lower than that of each monovalent vaccine, trivalent vaccine, and similar imported vaccine.

Key words: Escherichia coli, C-type Clostridium perfringens, inactivated vaccine, similar vaccine, safety test, immune protection test

CLC Number: